Lifescienceslab
Tendencias de investigación, analítica, diagnóstico y control de laboratorio
Antibody search engine CiteAb reaches 2 million milestone
University of Bath spin out company and leading antibody database CiteAb has announced today that it has listed its two millionth antibody.

This announcement cements CiteAb’s position as the world’s biggest antibody search engine, and places it far ahead of other comparable services.
The 2 millionth antibody was 4C5, Anti-DDK (FLAG tag) monoclonal antibody which is supplied by Rockville, USA-based company OriGene. This antibody is referenced in 29 publications, in which it has been shown to work in Western blotting and immunoprecipitation in human tissues.
CiteAb now gives researchers access to antibodies from 109 companies worldwide, including large multinationals, small specialist providers and not for profit academic groups. The 2 million antibodies listed on CiteAb are rated by over 400,000 citations.
CiteAb was developed in 2012 by University of Bath researcher Dr Andrew Chalmers, in collaboration with a web software development company Storm Consultancy, in response to a need among the research community for a fully independent antibody rating service.

The company spun out of the University of Bath in January 2014 and have since grown the exponentially.
Founder Dr Andrew Chalmers said: “We are extremely grateful to the community for providing us with fantastic support and helping us to build and develop a huge database which is now a valuable resource for all those carrying out research using antibodies.

“The excellent relationships we’ve developed with antibody suppliers, academic and industrial research institutions, journals and other companies in the sector has been essential in our growth over the last year and we extend our thanks to those who have provided invaluable support and advice along the way.

“The core ethos of CiteAb is that we are completely impartial – we list antibodies according to citations, so the only way an antibody can move up the ratings is to be used successfully in research and be cited by other researchers. We have only just begun on our journey and we have some very exciting plans for the future which we look forward to sharing with all of our friends.”
CiteAb has attracted month on month visitor growth since launching in March 2013.

Noticia publicada el jueves 17 de julio de 2014
Tendencias de investigación, analítica, diagnóstico y control de laboratorio
Espa?ol Español      English English
    
    




  Novedades de productos|Noticias del sector|Eventos|Asociaciones|Investigación

Antibody search engine CiteAb reaches 2 million milestone

University of Bath spin out company and leading antibody database CiteAb has announced today that it has listed its two millionth antibody.

This announcement cements CiteAb’s position as the world’s biggest antibody search engine, and places it far ahead of other comparable services.
The 2 millionth antibody was 4C5, Anti-DDK (FLAG tag) monoclonal antibody which is supplied by Rockville, USA-based company OriGene. This antibody is referenced in 29 publications, in which it has been shown to work in Western blotting and immunoprecipitation in human tissues.
CiteAb now gives researchers access to antibodies from 109 companies worldwide, including large multinationals, small specialist providers and not for profit academic groups. The 2 million antibodies listed on CiteAb are rated by over 400,000 citations.
CiteAb was developed in 2012 by University of Bath researcher Dr Andrew Chalmers, in collaboration with a web software development company Storm Consultancy, in response to a need among the research community for a fully independent antibody rating service.

The company spun out of the University of Bath in January 2014 and have since grown the exponentially.
Founder Dr Andrew Chalmers said: “We are extremely grateful to the community for providing us with fantastic support and helping us to build and develop a huge database which is now a valuable resource for all those carrying out research using antibodies.

“The excellent relationships we’ve developed with antibody suppliers, academic and industrial research institutions, journals and other companies in the sector has been essential in our growth over the last year and we extend our thanks to those who have provided invaluable support and advice along the way.

“The core ethos of CiteAb is that we are completely impartial – we list antibodies according to citations, so the only way an antibody can move up the ratings is to be used successfully in research and be cited by other researchers. We have only just begun on our journey and we have some very exciting plans for the future which we look forward to sharing with all of our friends.”
CiteAb has attracted month on month visitor growth since launching in March 2013.
  
Estándares XHTML

Estándares CSS

Descargue Firefox
Lifescienceslab es una publicación de la Editorial Omnimedia S.L. - C/ Rosa de Lima, Edificio Alba 1 Bis, Oficina 104. 28290 Las Matas (Madrid) - Teléfono: 902 36 46 99
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede obtener más información, o bien conocer cómo cambiar la configuración, en nuestra Política de cookies